Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.72 |
| ▸ | MEN1 | O00255 | 5/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | F2R | P25116 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28695522 | 0.83 | KMT2A (0.70) | KMT2AMEN1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL882734 | 0.83 | KMT2A (0.80) | KMT2AMEN1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL6426650 | 0.81 | KMT2A (0.69) | KMT2AMEN1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL10070482 | 0.81 | FABP4 (0.56) | KMT2AMEN1NPC1RAB9AFABP4 | |
| SCHEMBL6140750 | 0.78 | SIRT2 (0.59) | KMT2AMEN1NPC1RAB9AFABP4 | |
| SCHEMBL339194 | 0.77 | MEN1 (0.71) | KMT2AMEN1NPC1RAB9ATDP1 | |
| SCHEMBL12076664 | 0.77 | MEN1 (0.58) | KMT2AMEN1SMN1; SMN2RAB9AFABP4 | |
| SCHEMBL14363396 | 0.77 | ALDH1A1 (0.61) | KMT2AMEN1NPC1RAB9AL3MBTL1 | |
| SCHEMBL31092076 | 0.77 | HPGD (0.68) | KMT2AMEN1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL15770775 | 0.76 | MEN1 (0.53) | KMT2AMEN1FABP4MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2477979-B1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | NITTO DENKO CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-8808879-B2 | Phototherapy devices and methods comprising substituted carbazole compounds | NITTO DENKO CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8808879-B2 | Phototherapy devices and methods comprising substituted carbazole compounds | NITTO DENKO CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8808879-B2 | Phototherapy devices and methods comprising substituted carbazole compounds | NITTO DENKO CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8586205-B2 | Compounds for organic light emitting diode emissive layers | NITTO DENKO CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-8586205-B2 | Compounds for organic light emitting diode emissive layers | NITTO DENKO CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| EP-2477979-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | Nitto Denko Corporation (JP) | 2012-07-25 | — | — | EP | disclosed |
| WO-2012012295-A1 | PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-26 | — | — | WO | disclosed |
| WO-2012012295-A1 | PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-26 | — | — | WO | disclosed |
| US-20120016449-A1 | PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20120016449-A1 | PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| WO-2011034967-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | NITTO DENKO CORPORATION (JP) | 2011-03-24 | — | — | WO | disclosed |
| WO-2011034967-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | NITTO DENKO CORPORATION (JP) | 2011-03-24 | — | — | WO | disclosed |
| US-20110062386-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | NITTO DENKO CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20110062386-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | NITTO DENKO CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20110062386-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | NITTO DENKO CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016449-A1 | PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS | TYR, PPOX, CRY1 | KMT2A 710/4885MEN1 2684/4885SMN1; SMN2 1851/4885 |
| US-20110062386-A1 | COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS | ALOX12, ALOX15B, ALOX15 | KMT2A 1816/4885MEN1 1773/4885SMN1; SMN2 4267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.